Nova Mentis Announces Change of Directors and Officers
Vancouver, British Columbia – January 03, 2023 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”) announces the appointment of Dr. Georg Hochwimmer to the Company’s Board of Directors, effective December 29, 2023.
Dr. Hochwimmer is Chief Analyst at General Research, GmbH, a leading Munich-based securities research and analysis firm. Dr. Hochwimmer is a noted business consultant and academic...